Skip to content

Verrica Pharmaceuticals Inc.

VRCA· Nasdaqxbrl foundCIK 1660334

Pharmaceutical preparations552 peers

Last sale
Nov 5, 2026 · -9.14%
Market cap
$52.91M
17.18M shares
Filings
538
$6.91M
Q3 2026+370.2% FY25 yoy
-$12.41M
Q3 2026N/M FY25 yoy
-$12.17M
Q3 2026N/M FY25 yoy
-$17.63M
FY 2025derivedN/M FY25 yoy
-$0.58
Q3 2026N/M FY25 yoy
$14.39M
Q3 2026−34.9% FY25 yoy
$52.91M
—
2.3×
—
—
—

Twelve months to Sep 30, 2026 · derived

Price

$3.088.88%$0.30past year
Nov 5, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$35.58MFY 2025
$35.58M0FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$35,577,000reported
FY 20242024-12-31$7,566,000reported
FY 20232023-12-31$5,124,000reported
FY 20222022-12-31$9,032,000reported
FY 20212021-12-31$12,000,000reported

Segments

Products
Revenue by Products, FY2022 to FY2025FY2022Collaboration · FY2022 · $9.03MFY2023Collaboration · FY2023 · $466.00KProduct · FY2023 · $4.66MFY2024License and Collaboration Revenue, Commercial Supply and Development · FY2024 · $1.00MCollaboration · FY2024 · $992.00KProduct · FY2024 · $6.57MFY2025License and Collaboration Revenue, Commercial Supply and Development · FY2025 · $2.30M
LineFY2025ShareChange
License and Collaboration Revenue, Commercial Supply and Development$2.30M6.5%+130.0%
Collaboration———
Product———
Total$35.58M

From the 10-K filed Mar 11, 2026VRCA

Pharmaceutical preparations

Verrica Pharmaceuticals Inc. is the 142nd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Verrica Pharmaceuticals Inc. · CIK 1660334 · Engraved from SEC EDGAR